FORM 10-Q
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
x | Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 |
For the quarterly period ended December 31, 2004
¨ | Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 |
for the transition period from to .
Commission File Number: 0-16195
II-VI INCORPORATED
(Exact name of registrant as specified in its charter)
PENNSYLVANIA | 25-1214948 | |
(State or other jurisdiction of incorporation or organization) |
(I.R.S. Employer Identification No.) |
375 Saxonburg Boulevard Saxonburg, PA |
16056 | |
(Address of principal executive offices) | (Zip Code) |
Registrants telephone number, including area code: 724-352-4455
N/A
(Former name, former address and former fiscal year, if changed since last report)
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No ¨
Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act). Yes x No ¨
Indicate the number of shares outstanding of each of the issuers classes of common stock as of the latest practicable date:
At February 4, 2005, 14,574,327 shares of Common Stock, no par value, of the registrant were outstanding.
II-VI INCORPORATED
2
PART I - FINANCIAL INFORMATION
II-VI Incorporated and Subsidiaries
Consolidated Balance Sheets (Unaudited)
($000)
December 31, 2004 |
June 30, 2004 | |||||
Assets |
||||||
Current Assets |
||||||
Cash and cash equivalents |
$ | 16,270 | $ | 21,683 | ||
Accounts receivable less allowance for doubtful accounts and warranty returns of $1,905 at December 31, 2004 and $1,343 at June 30, 2004 |
28,622 | 25,540 | ||||
Inventories |
41,449 | 29,201 | ||||
Deferred income taxes |
7,280 | 4,561 | ||||
Prepaid and other current assets |
1,956 | 1,595 | ||||
Total Current Assets |
95,577 | 82,580 | ||||
Property, Plant & Equipment, net |
73,445 | 62,339 | ||||
Goodwill |
46,653 | 28,987 | ||||
Investment |
2,004 | 1,888 | ||||
Intangible Assets, net |
5,675 | 5,852 | ||||
Other Assets |
3,692 | 2,288 | ||||
$ | 227,046 | $ | 183,934 | |||
Liabilities and Shareholders Equity |
||||||
Current Liabilities |
||||||
Accounts payable |
$ | 8,816 | $ | 8,337 | ||
Accrued salaries and wages |
4,770 | 3,291 | ||||
Accrued bonuses |
4,004 | 7,386 | ||||
Income taxes payable |
3,249 | 4,295 | ||||
Accrued profit sharing contribution |
1,173 | 2,122 | ||||
Other accrued liabilities |
3,588 | 2,815 | ||||
Current portion of long-term debt |
51 | 7,550 | ||||
Total Current Liabilities |
25,651 | 35,796 | ||||
Long-Term Debt less current portion |
43,660 | 7,986 | ||||
Deferred Income Taxes |
7,975 | 6,177 | ||||
Other Liabilities |
3,464 | 2,108 | ||||
Total Liabilities |
80,750 | 52,067 | ||||
Commitments and Contingencies |
||||||
Shareholders Equity |
||||||
Preferred stock, no par value; authorized - 5,000,000 shares; none issued |
| | ||||
Common stock, no par value; authorized 100,000,000 shares at December 31, 2004 and 30,000,000 shares at June 30, 2004; issued 15,641,327 shares at December 31, 2004 and 15,520,713 shares at June 30, 2004 |
44,608 | 42,429 | ||||
Accumulated other comprehensive income, net of income taxes |
1,579 | 1,081 | ||||
Retained earnings |
102,019 | 90,267 | ||||
148,206 | 133,777 | |||||
Less treasury stock, at cost, 1,068,880 shares |
1,910 | 1,910 | ||||
Total Shareholders Equity |
146,296 | 131,867 | ||||
$ | 227,046 | $ | 183,934 | |||
- See notes to consolidated financial statements.
3
II-VI Incorporated and Subsidiaries
Consolidated Statements of Earnings (Unaudited)
($000 except per share data)
Three Months Ended December 31, |
||||||||
2004 |
2003 |
|||||||
Revenues |
||||||||
Net sales: |
||||||||
Domestic |
$ | 23,727 | $ | 13,201 | ||||
International |
17,728 | 19,772 | ||||||
41,455 | 32,973 | |||||||
Contract research and development |
1,758 | 1,662 | ||||||
43,213 | 34,635 | |||||||
Costs, Expenses & Other (Income) |
||||||||
Cost of goods sold |
23,180 | 18,991 | ||||||
Contract research and development |
916 | 1,376 | ||||||
Internal research and development |
1,584 | 1,367 | ||||||
Selling, general and administrative |
9,713 | 7,782 | ||||||
Interest expense |
88 | 117 | ||||||
Other (income), net |
(203 | ) | (149 | ) | ||||
35,278 | 29,484 | |||||||
Earnings Before Income Taxes |
7,935 | 5,151 | ||||||
Income Taxes |
2,142 | 1,727 | ||||||
Net Earnings |
$ | 5,793 | $ | 3,424 | ||||
Basic Earnings Per Share |
$ | 0.40 | $ | 0.24 | ||||
Diluted Earnings Per Share |
$ | 0.39 | $ | 0.23 | ||||
- See notes to consolidated financial statements.
4
II-VI Incorporated and Subsidiaries
Consolidated Statements of Earnings (Unaudited)
($000 except per share data)
Six Months Ended December 31, |
||||||||
2004 |
2003 |
|||||||
Revenues |
||||||||
Net sales: |
||||||||
Domestic |
$ | 45,459 | $ | 30,568 | ||||
International |
33,820 | 34,458 | ||||||
79,279 | 65,026 | |||||||
Contract research and development |
4,441 | 3,703 | ||||||
83,720 | 68,729 | |||||||
Costs, Expenses & Other (Income) |
||||||||
Cost of goods sold |
43,594 | 37,057 | ||||||
Contract research and development |
3,224 | 3,367 | ||||||
Internal research and development |
2,632 | 2,454 | ||||||
Selling, general and administrative |
18,714 | 16,008 | ||||||
Interest expense |
151 | 251 | ||||||
Other (income), net |
(694 | ) | (240 | ) | ||||
67,621 | 58,897 | |||||||
Earnings Before Income Taxes |
16,099 | 9,832 | ||||||
Income Taxes |
4,347 | 3,294 | ||||||
Net Earnings |
$ | 11,752 | $ | 6,538 | ||||
Basic Earnings Per Share |
$ | 0.81 | $ | 0.46 | ||||
Diluted Earnings Per Share |
$ | 0.79 | $ | 0.45 | ||||
- See notes to consolidated financial statements.
5
II-VI Incorporated and Subsidiaries
Condensed Consolidated Statements of Cash Flows (Unaudited)
($000)
Six Months Ended December 31, |
||||||||
2004 |
2003 |
|||||||
Cash Flows from Operating Activities |
||||||||
Net earnings |
$ | 11,752 | $ | 6,538 | ||||
Adjustments to reconcile net earnings to net cash provided by operating activities: |
||||||||
Depreciation |
5,185 | 4,456 | ||||||
Amortization |
358 | 289 | ||||||
Gain on foreign currency remeasurements and transactions |
(754 | ) | (188 | ) | ||||
Net (gain) loss on disposal or writedown of assets |
(4 | ) | 114 | |||||
Deferred income taxes |
99 | 912 | ||||||
Increase (decrease) in cash from changes in: |
||||||||
Accounts receivable |
2,385 | 1,634 | ||||||
Inventories |
(7,524 | ) | (2,020 | ) | ||||
Accounts payable |
(2,725 | ) | (731 | ) | ||||
Other operating net assets |
(5,505 | ) | (491 | ) | ||||
Net cash provided by operating activities |
3,267 | 10,513 | ||||||
Cash Flows from Investing Activities |
||||||||
Additions to property, plant and equipment |
(7,975 | ) | (5,719 | ) | ||||
Proceeds from sale of property, plant and equipment |
65 | | ||||||
Purchase of businesses, net of cash acquired |
(29,650 | ) | (1,954 | ) | ||||
Dividend from unconsolidated business |
10 | 8 | ||||||
Net cash used in investing activities |
(37,550 | ) | (7,665 | ) | ||||
Cash Flows from Financing Activities |
||||||||
Proceeds on short-term borrowings |
15,400 | 4,000 | ||||||
Payments on short-term borrowings |
(8,000 | ) | (4,250 | ) | ||||
Proceeds on long-term borrowings |
30,000 | | ||||||
Payments on long-term borrowings |
(9,400 | ) | (3,147 | ) | ||||
Proceeds from exercise of stock options |
1,029 | 586 | ||||||
Net cash provided by (used in) financing activities |
29,029 | (2,811 | ) | |||||
Effect of exchange rate changes on cash and cash equivalents |
(159 | ) | (361 | ) | ||||
Net decrease in cash and cash equivalents |
(5,413 | ) | (324 | ) | ||||
Cash and Cash Equivalents at Beginning of Period |
21,683 | 15,583 | ||||||
Cash and Cash Equivalents at End of Period |
$ | 16,270 | $ | 15,259 | ||||
Non-cash transactions: |
||||||||
Accrued purchase price for assets acquired |
$ | | $ | 1,800 | ||||
Cash paid for interest |
$ | 217 | $ | 280 | ||||
Cash paid for income taxes |
$ | 3,480 | $ | 2,079 | ||||
- See notes to consolidated financial statements.
6
II-VI Incorporated and Subsidiaries
Notes to Consolidated Financial Statements (Unaudited)
Note A - Basis of Presentation
The consolidated financial statements for the three and six month periods ended December 31, 2004 and 2003 are unaudited. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation for the periods presented have been included. Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted. These consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto in the Corporations annual report on Form 10-K for the year ended June 30, 2004. The consolidated results of operations for the three and six month periods ended December 31, 2004 and 2003 are not necessarily indicative of the results to be expected for the full year. The results for the three and six month periods ended December 31, 2004 include one month of operations of the Companys recently acquired Marlow Industries, Inc. subsidiary.
Certain amounts from the prior period financial statements have been reclassified to conform with current period presentation.
Note B - Contract Receivables
The components of contract receivables, which are a component of accounts receivable, net, were as follows ($000):
December 31, 2004 |
June 30, 2004 | |||||
Billed |
$ | 1,626 | $ | 721 | ||
Unbilled |
1,560 | 1,755 | ||||
$ | 3,186 | $ | 2,476 | |||
Note C - Inventories
The components of inventories were as follows ($000):
December 31, 2004 |
June 30, 2004 | |||||
Raw materials |
$ | 9,230 | $ | 7,700 | ||
Work in progress |
17,096 | 13,441 | ||||
Finished goods |
15,123 | 8,060 | ||||
$ | 41,449 | $ | 29,201 | |||
7
II-VI Incorporated and Subsidiaries
Notes to Consolidated Financial Statements (Unaudited), Continued
Note D - Property, Plant and Equipment
Property, plant and equipment (at cost or valuation) consist of the following ($000):
December 31, 2004 |
June 30, 2004 | |||||
Land and land improvements |
$ | 1,842 | $ | 1,453 | ||
Buildings and improvements |
34,279 | 32,068 | ||||
Machinery and equipment |
89,569 | 74,397 | ||||
Construction in progress |
7,543 | 9,852 | ||||
133,233 | 117,770 | |||||
Less accumulated depreciation |
59,788 | 55,431 | ||||
$ | 73,445 | $ | 62,339 | |||
Capitalized interest expense associated with the Companys expansion of its coating facility and administrative offices at its Saxonburg, Pennsylvania facility was $34,000 and $96,000 for the three and six months ended December 31, 2004, respectively. No interest was capitalized during the three and six month periods ended December 31, 2003.
Note E - Goodwill and Intangible Assets
In connection with the acquisition of Marlow Industries, Inc. in December 2004, the Company recorded the excess purchase price over the net assets of the business acquired as goodwill in the accompanying Consolidated Balance Sheet based on the preliminary purchase price allocation. The Company is presently in the process of obtaining a third-party valuation of the intangible assets acquired from Marlow Industries Inc. and finalizing their deferred income tax assets and liabilities; thus the allocation of purchase price among goodwill, intangible assets not subject to amortization, intangible assets subject to amortization and deferred income tax assets and liabilities as well as determination of their related amortization periods, has not yet been finalized and are therefore subject to adjustment in future periods. The Company anticipates finalizing its accounting for the purchase of Marlaw Industries, Inc. by June 30, 2005 (see Note N).
Changes in the carrying amount of goodwill are as follows ($000):
December 31, 2004 |
June 30, 2004 | |||||
Balance Beginning of Period |
$ | 28,987 | $ | 28,987 | ||
Goodwill acquired Marlow Industries, Inc. |
17,666 | | ||||
Balance End of period |
$ | 46,653 | $ | 28,987 | ||
8
II-VI Incorporated and Subsidiaries
Notes to Consolidated Financial Statements (Unaudited), Continued
Note E - Goodwill and Intangible Assets, Contd.
The gross carrying amount and accumulated amortization of the Companys intangible assets other than goodwill were as follows ($000):
December 31, 2004 |
June 30, 2004 | |||||||||||||||||||
Gross Carrying Amount |
Accumulated Amortization |
Net Book Value |
Gross Carrying Amount |
Accumulated Amortization |
Net Book Value | |||||||||||||||
Patents |
$ | 2,681 | $ | (803 | ) | $ | 1,878 | $ | 2,681 | $ | (693 | ) | $ | 1,988 | ||||||
Trademark |
1,491 | (329 | ) | 1,162 | 1,491 | (292 | ) | 1,199 | ||||||||||||
Customer Lists |
3,653 | (1,100 | ) | 2,553 | 3,400 | (854 | ) | 2,546 | ||||||||||||
Other |
750 | (668 | ) | 82 | 750 | (631 | ) | 119 | ||||||||||||
Total |
$ | 8,575 | $ | (2,900 | ) | $ | 5,675 | $ | 8,322 | $ | (2,470 | ) | $ | 5,852 | ||||||
Amortization expense recorded on the intangible assets was $181,000 and $358,000 for the three and six month periods ended December 31, 2004 and $158,000 and $289,000 for the three and six months period ended December 31, 2003. Included in the gross carrying amount and accumulated amortization of the Companys customer lists component of intangible assets is the effect of the foreign currency translation of the portion relating to the Companys majority-owned subsidiaries in Germany and Switzerland. At December 31, 2004, the estimated amortization expense for existing intangible assets for each of the five succeeding fiscal years were as follows ($000):
Year Ended June 30, |
|||
Remaining fiscal 2005 |
$ | 358 | |
2006 |
659 | ||
2007 |
561 | ||
2008 |
552 | ||
2009 |
552 |
Note F - Debt
The components of debt were as follows ($000s):
December 31, 2004 |
June 30, 2004 |
|||||||
Line of credit, interest at the LIBOR Rate, as defined, plus 1.00% |
$ | 10,400 | $ | | ||||
Term loan, interest at the LIBOR Rate, as defined, plus 1.00% payable in installments beginning in January 2006. |
30,000 | | ||||||
Line of credit, interest at the LIBOR Rate, as defined, plus 0.88%. |
| 3,000 | ||||||
Term loan, interest at the LIBOR Rate, as defined, plus 0.88%. |
| 9,375 | ||||||
Pennsylvania Industrial Development Authority term note, interest at 3.00%, payable in monthly installments through October 2011 |
379 | 404 | ||||||
Yen denominated term note, interest at the Japanese Yen Base Rate, as defined, plus 1.49%, principal payable in full in September 2007 |
2,932 | 2,757 | ||||||
Total debt |
43,711 | 15,536 | ||||||
Current portion of long-term debt |
(51 | ) | (7,550 | ) | ||||
Long-term debt |
$ | 43,660 | $ | 7,986 | ||||
9
II-VI Incorporated and Subsidiaries
Notes to Consolidated Financial Statements (Unaudited), Continued
Note F - Debt, Contd.
On December 10, 2004, the Company replaced its $45.0 million secured credit facility with a $60.0 million secured credit facility in connection with the Companys acquisition of Marlow Industries, Inc. This facility has a five-year term and contains a term option in the original amount of $30.0 million and a $30.0 million line of credit option. The facility is collateralized by a pledge of 65% of the stock of certain of the Companys foreign subsidiaries. Additionally, the facility is subject to certain restrictive covenants, including those relating to minimum net worth, leverage and consolidated debt service coverage. The facility has an interest rate range of LIBOR plus 0.75% to LIBOR plus 1.50%. Principal payments of $1.9 million under the term loan are payable in quarterly installments beginning January 1, 2006. The weighted average interest rate of borrowings under the new credit agreement was 3.60% at December 31, 2004. The Company had available $19.1 million under its line of credit as of December 31, 2004.
At December 31, 2004 and June 30, 2004, total outstanding letters of credit supported by the facilities were $0.5 million and $0.4 million, respectively.
The Company has a 300 million Yen loan. The loan matures on September 25, 2007. Interest is at a rate equal to the Japanese Yen base rate, as defined in the loan agreement, plus 1.49%. The Japanese Yen base rate was 0.07% at December 31, 2004 and 0.06% at June 30, 2004.
Note G - Earnings Per Share
The following table sets forth the computation of earnings per share for the periods indicated. Weighted average shares issuable upon the exercise of stock options that were not included in the calculation because they were antidilutive were immaterial for all periods presented ($000 except per share data):
Three Months Ended December 31, |
Six Months Ended December 31, | |||||||||||
2004 |
2003 |
2004 |
2003 | |||||||||
Net earnings |
$ | 5,793 | $ | 3,424 | $ | 11,752 | $ | 6,538 | ||||
Divided by: |
||||||||||||
Weighted average shares |
14,558 | 14,285 | 14,521 | 14,256 | ||||||||
Basic earnings per share |
$ | 0.40 | $ | 0.24 | $ | 0.81 | $ | 0.46 | ||||
Net earnings |
$ | 5,793 | $ | 3,424 | $ | 11,752 | $ | 6,538 | ||||
Divided by: |
||||||||||||
Weighted average shares |
14,558 | 14,285 | 14,521 | 14,256 | ||||||||
Dilutive effect of common stock equivalents |
434 | 386 | 430 | 400 | ||||||||
Diluted weighted average common shares |
14,992 | 14,671 | 14,951 | 14,656 | ||||||||
Diluted earnings per share |
$ | 0.39 | $ | 0.23 | $ | 0.79 | $ | 0.45 | ||||
10
II-VI Incorporated and Subsidiaries
Notes to Consolidated Financial Statements (Unaudited), Continued
Note H - Comprehensive Income
The components of comprehensive income were as follows for the periods indicated ($000):
Three Months Ended December 31, |
Six Months Ended December 31, | |||||||||||
2004 |
2003 |
2004 |
2003 | |||||||||
Net earnings |
$ | 5,793 | $ | 3,424 | $ | 11,752 | $ | 6,538 | ||||
Other comprehensive income (loss): |
||||||||||||
Foreign currency translation adjustments net of income tax expense of $275 and $184, respectively, for the three and six months ended December 31, 2004 and $254 and $283, respectively, for the three and six months ended December 31, 2003. |
743 | 505 | 498 | 562 | ||||||||
Comprehensive income |
$ | 6,536 | $ | 3,929 | $ | 12,250 | $ | 7,100 | ||||
Note I - Segment Reporting
The Company reports its segments using the management approach model for segment reporting. The management approach model is based on the way a companys management organizes segments within the company for making operating decisions and assessing performance. Reportable segments are based on products and services, geography, legal structure, management structure or any other manner in which management segregates a company.
The Companys reportable segments offer similar products to different target markets. The segments are managed separately due to the production requirements and facilities that are unique to each segment. The Company has the following reportable segments: Infrared Optics, which is the Companys II-VI infrared optics and material products businesses and remaining corporate activities, primarily corporate assets and capital expenditures; Near-Infrared Optics, which is the Companys VLOC subsidiary and the Suzhou, China near-infrared operations; Military Infrared Optics, which is the Companys Exotic Electro-Optics subsidiary; and Compound Semiconductor Group, which is the aggregation of the Companys eV PRODUCTS division, the Companys Wide Bandgap Materials (WBG) group, the Companys Advanced Material Development Center (AMDC) group, (which is responsible for corporate research and development activities) and Marlow Industries, Inc. beginning December 2004. As noted in Note A, one month of financial results of Marlow Industries, Inc. are included in the segment information for both the three and six months ended December 31, 2004.
The Infrared Optics segment is divided into the geographic locations in the United States, Singapore, China, Germany, Switzerland, Japan, Belgium and the United Kingdom. An Executive Vice-President of the Company directs the segment, while each geographic location is directed by a general manager, and is further divided into production and administrative units that are directed by managers. The Infrared Optics segment designs, manufactures and markets optical and electro-optical components and materials sold under the II-VI brand name and used primarily in high-power CO2 lasers.
The Near-Infrared Optics segment is located in the United States and China. The Near-Infrared Optics segment is directed by a general manager. The Near-Infrared Optics segment is further divided into production and administrative units that are directed by managers. The Near-Infrared Optics segment designs, manufactures and markets near-infrared and visible-light products for industrial, scientific and medical instruments and laser gain material and products for solid-state YAG and YLF lasers.
11
The Military Infrared Optics segment is located in the United States. The Military Infrared Optics segment is directed by a general manager with oversight by a Corporate Vice-President. The Military Infrared Optics segment is further divided into production and administrative units that are directed by managers. The Military Infrared Optics segment designs, manufactures and markets infrared products for military applications under the Exotic Electro-Optics brand name.
The Compound Semiconductor Group is located in the United States, the United Kingdom and Japan. The Compound Semiconductor Group segment is directed by a Group Vice-President. The Companys eV PRODUCTS division manufactures and markets solid-state x-ray and gamma-ray sensor materials and products for use in medical, security monitoring, industrial, environmental and scientific applications. The Companys WBG group manufactures and markets single crystal silicon carbide substrates for use in solid-state lighting, wireless infrastructure, radio frequency (RF) electronics and power switching industries. The Companys AMDC group directs the corporate research and development initiatives. The Companys Marlow Industries, Inc. subsidiary designs and manufacturers thermoelectric cooling and power generation solutions for use in defense, space, photonics, telecommunications, medical, consumer and industrial markets.
The accounting policies of the segments are the same as those of the Company. Substantially all of the Companys corporate expenses are allocated to the segments. The Company evaluates segment performance based upon reported segment earnings or loss, which is defined as earnings before income taxes, interest and other income or expense. Inter-segment sales and transfers have been eliminated.
12
II-VI Incorporated and Subsidiaries
Notes to Consolidated Financial Statements (Unaudited), Continued
Note I - Segment Reporting, Contd.
The following table summarizes selected financial information of the Companys operations by segment ($000s):
Three Months Ended December 31, 2004 |
||||||||||||||||||||
Infrared Optics |
Near-Infrared Optics |
Military Infrared Optics |
Compound Semiconductor Group |
Eliminations |
Totals |
|||||||||||||||
Revenues |
$ | 23,513 | $ | 8,313 | $ | 6,684 | $ | 4,703 | | $ | 43,213 | |||||||||
Inter-segment revenues |
115 | 1,044 | 91 | 951 | (2,201 | ) | | |||||||||||||
Segment earnings (loss) |
7,705 | 531 | 358 | (774 | ) | | 7,820 | |||||||||||||
Interest expense |
| | | | | (88 | ) | |||||||||||||
Other income, net |
| | | | | 203 | ||||||||||||||
Earnings before income taxes |
| | | | | 7,935 | ||||||||||||||
Depreciation and amortization |
1,177 | 674 | 445 | 638 | | 2,934 | ||||||||||||||
Segment assets |
102,635 | 29,183 | 40,748 | 54,480 | | 227,046 | ||||||||||||||
Expenditures for property, plant and equipment |
2,236 | 740 | 147 | 655 | | 3,778 | ||||||||||||||
Equity investment |
| | | 2,004 | | 2,004 | ||||||||||||||
Goodwill, net |
5,516 | 1,927 | 21,544 | 17,666 | | 46,653 | ||||||||||||||
Three Months Ended December 31, 2003 |
||||||||||||||||||||
Infrared Optics |
Near-Infrared Optics |
Military Infrared Optics |
Compound Semiconductor Group |
Eliminations |
Totals |
|||||||||||||||
Revenues |
$ | 19,891 | $ | 5,181 | $ | 6,517 | $ | 3,046 | | $ | 34,635 | |||||||||
Inter-segment revenues |
275 | 844 | | 17 | (1,136 | ) | | |||||||||||||
Segment earnings (loss) |
5,158 | 148 | 245 | (432 | ) | | 5,119 | |||||||||||||
Interest expense |
| | | | | (117 | ) | |||||||||||||
Other income, net |
| | | | | 149 | ||||||||||||||
Earnings before income taxes |
| | | | | 5,151 | ||||||||||||||
Depreciation and amortization |
987 | 602 | 381 | 417 | | 2,387 | ||||||||||||||
Segment assets |
86,120 | 26,439 | 38,648 | 17,674 | | 168,881 | ||||||||||||||
Expenditures for property, plant and equipment |
1,504 | 313 | 687 | 377 | | 2,881 | ||||||||||||||
Equity investment |
| | | 1,785 | | 1,785 | ||||||||||||||
Goodwill, net |
5,516 | 1,927 | 21,544 | | | 28,987 |
13
II-VI Incorporated and Subsidiaries
Notes to Consolidated Financial Statements (Unaudited), Continued
Note I - Segment Reporting, Contd.
Six Months Ended December 31, 2004 |
||||||||||||||||||||
Infrared Optics |
Near-Infrared Optics |
Military Infrared Optics |
Compound Semiconductor Group |
Eliminations |
Totals |
|||||||||||||||
Revenues |
$ | 46,578 | $ | 16,060 | $ | 13,095 | $ | 7,987 | | $ | 83,720 | |||||||||
Inter-segment revenues |
209 | 1,811 | 186 | 1,840 | (4,046 | ) | | |||||||||||||
Segment earnings (loss) |
15,240 | 997 | 639 | (1,320 | ) | | 15,556 | |||||||||||||
Interest expense |
| | | | | (151 | ) | |||||||||||||
Other income, net |
| | | | | 694 | ||||||||||||||
Earnings before income taxes |
| | | | | 16,099 | ||||||||||||||
Depreciation and amortization |
2,299 | 1,317 | 835 | 1,092 | | 5,543 | ||||||||||||||
Expenditures for property, plant and equipment |
4,754 | 1,554 | 597 | 1,070 | | 7,975 | ||||||||||||||
Six Months Ended December 31, 2003 |
||||||||||||||||||||
Infrared Optics |
Near-Infrared Optics |
Military Infrared Optics |
Compound Semiconductor Group |
Eliminations |
Totals |
|||||||||||||||
Revenues |
$ | 39,797 | $ | 11,132 | $ | 12,199 | $ | 5,601 | | $ | 68,729 | |||||||||
Inter-segment revenues |
446 | 1,130 | | 32 | (1,608 | ) | | |||||||||||||
Segment earnings (loss) |
10,609 | 692 | 239 | (1,697 | ) | | 9,843 | |||||||||||||
Interest expense |
| | | | | (251 | ) | |||||||||||||
Other income, net |
| | | | | 240 | ||||||||||||||
Earnings before income taxes |
| | | | | 9,832 | ||||||||||||||
Depreciation and amortization |
1,969 | 1,160 | 790 | 826 | | 4,745 | ||||||||||||||
Expenditures for property, plant and equipment |
2,490 | 723 | 1,009 | 1,497 | | 5,719 |
14
II-VI Incorporated and Subsidiaries
Notes to Consolidated Financial Statements (Unaudited), Continued
Note J - Derivative Instruments
SFAS No. 133 Accounting for Derivative Instruments and Hedging Activities, as amended, establishes accounting and reporting standards for derivative instruments and hedging activities. It requires that an entity recognize all derivatives as either assets or liabilities in the statement of financial position and measure those instruments at fair value.
The Company from time to time purchases foreign currency forward exchange contracts, primarily in Japanese Yen, that permit it to sell specified amounts of these foreign currencies expected to be received from its export sales for pre-established U.S. dollar amounts at specified dates. These contracts are entered into to limit transactional exposure to changes in currency exchange rates of export sales transactions in which settlement will occur in future periods and which otherwise would expose the Company, on the basis of its aggregate net cash flows in respective currencies, to foreign currency risk.
The Company recorded the fair value of contracts with a notional amount of approximately $5.4 million and $3.3 million as of December 31, 2004 and June 30, 2004, respectively. These amounts were recorded in Other accrued liabilities as of December 31, 2004 and June 30, 2004 on the Consolidated Balance Sheets. The Company does not account for these contracts as hedges as defined by SFAS No. 133 and records the change in the fair value of these contracts in the results of operations as they occur. The change in the fair value of these contracts decreased net earnings by $168,000 and increased net earnings by $58,000 for the three months ended December 31, 2004 and December 31, 2003, respectively. The change in the fair value of these contracts decreased net earnings by $91,000 and $79,000 for the six months ended December 31, 2004 and December 31, 2003, respectively.
To satisfy certain provisions of its former credit facility (see Note F), on March 9, 2004 the Company entered into a one-year interest rate cap with a notional amount of $5.6 million replacing an interest rate cap that expired on March 6, 2004. These agreements were entered into to limit interest rate exposure on one-half of the remaining outstanding balance of the Companys term loan under the former credit agreement. The floating rate option for the cap agreement is the one-month LIBOR rate with a cap strike rate of 2.00%. At December 31, 2004 the one-month LIBOR rate was 2.40%. The Company has elected not to account for these agreements as hedges as defined by SFAS No. 133 but instead recorded the unrealized change in the fair value of these agreements as an increase or decrease to interest expense in the results of operations. The effect of the interest rate cap on net earnings for the three and six months ended December 31, 2004 was insignificant. Under the terms of the new credit facility, within ninety calendar days of the closing date of the new facility, the Company is required to enter into one or more interest rate protection agreements covering at least 50% of the principal amount of the term loan. The Company expects that this interest rate protection agreement will be in place by the required date.
15
II-VI Incorporated and Subsidiaries
Notes to Consolidated Financial Statements (Unaudited), Continued
Note K - Stock-Based Compensation
The Company uses the intrinsic value approach of APB Opinion No. 25 for stock options granted to officers and key employees. All options granted under the plan had an exercise price equal to the fair market value of the underlying common stock on the date of grant.
In accordance with the disclosure requirements of SFAS No. 148, the following pro forma information adjusts previously reported net earnings, basic earnings per common share and diluted earnings per common share to reflect the fair value recognition provisions of SFAS No. 123 ($000 except per share data).
Three Months Ended December 31, 2004 |
Three Months Ended December 31, 2003 |
|||||||||||||||||||||||
Net Earnings |
Basic Earnings Per Common Share |
Diluted Earnings Per Common Share |
Net Earnings |
Basic Earnings Per Common Share |
Diluted Earnings Per Common Share |
|||||||||||||||||||
Net earnings and earnings per common share, as reported | $ | 5,793 | $ | 0.40 | $ | 0.39 | $ | 3,424 | $ | 0.24 | $ | 0.23 | ||||||||||||
Add: Stock-based employee compensation cost, net of related income tax effects, recorded in the financial statements | | | | | | | ||||||||||||||||||
Deduct: Stock-based employee compensation cost, net of related income tax effects, that would have been included in the determination of net earnings if the fair value method had been applied to all awards | (399 | ) | (0.03 | ) | (0.03 | ) | (171 | ) | (0.01 | ) | (0.01 | ) | ||||||||||||
Pro forma net earnings and earnings per common share | $ | 5,394 | $ | 0.37 | $ | 0.36 | $ | 3,253 | $ | 0.23 | $ | 0.22 | ||||||||||||
16
II-VI Incorporated and Subsidiaries
Notes to Consolidated Financial Statements (Unaudited), Continued
Note K - Stock-Based Compensation, Contd.
Six Months Ended December 31, 2004 |
Six Months Ended December 31, 2003 |
|||||||||||||||||||||||
Net Earnings |
Basic Share |
Diluted Earnings Per Common Share |
Net Earnings |
Basic Earnings Per Common Share |
Diluted Earnings Per Common Share |
|||||||||||||||||||
Net earnings and earnings per common share, as reported | $ | 11,752 | $ | 0.81 | $ | 0.79 | $ | 6,538 | $ | 0.46 | $ | 0.45 | ||||||||||||
Add: Stock-based employee compensation cost, net of related income tax effects, recorded in the financial statements | | | | | | | ||||||||||||||||||
Deduct: Stock-based employee compensation cost, net of related income tax effects, that would have been included in the determination of net earnings if the fair value method had been applied to all awards | (719 | ) | (0.05 | ) | (0.05 | ) | (341 | ) | (0.02 | ) | (0.02 | ) | ||||||||||||
Pro forma net earnings and earnings per common share | $ | 11,033 | $ | 0.76 | $ | 0.74 | $ | 6,197 | $ | 0.44 | $ | 0.43 | ||||||||||||
The pro forma adjustments were calculated using the Black-Scholes option pricing model under the following weighted-average assumptions in each period:
Three Months Ended December 31, 2004 |
Three Months Ended December 31, 2003 |
Six Months Ended December 31, 2004 |
Six Months Ended December 31, 2003 |
|||||||||
Risk free interest rate |
4.06 | % | 3.63 | % | 3.77 | % | 3.61 | % | ||||
Expected volatility |
64 | % | 64 | % | 64 | % | 64 | % | ||||
Expected life of options |
7.11 years | 7.04 years | 7.11 years | 7.04 years | ||||||||
Expected dividends |
none | none | none | none |
During December 2004, the FASB issued Statement of Financial Accounting Standards No. 123 (Revised 2004) Share-Based Payment (SFAS 123(R)), which amends SFAS No. 123 Accounting for Stock-Based Compensation and SFAS 95 Statement of Cash Flows. SFAS 123(R) requires all companies to measure compensation cost for all share-based payments (including employee stock options) at fair value, and will be effective for public companies for interim or annual periods beginning after June 15, 2005. The Company is currently evaluating the effect that the accounting change will have on its financial position and results of operations.
17
II-VI Incorporated and Subsidiaries
Notes to Condensed Consolidated Financial Statements (Unaudited), Continued
Note L - Warranty Reserve
The Company records a warranty reserve as a charge against earnings based on a percentage of sales utilizing actual returns over the last twelve months.
The following table summarizes the change in the carrying value of the Companys warranty reserve as of and for the six months ended December 31, 2004 and as of and for the year ended June 30, 2004 ($000).
Six Months Ended December 31, 2004 |
Year Ended June 30, 2004 | |||||
Balance Beginning of Period |
$ | 552 | $ | 504 | ||
Expense and writeoffs, net |
159 | 48 | ||||
Other |
217 | | ||||
Balance End of Period |
$ | 928 | $ | 552 | ||
The component of Other relates to the warranty reserve from the acquisition of Marlow Industries, Inc. in December 2004 (see Note O).
Note M - Investment in 5N Plus, Inc.
The Company has a 33% equity ownership interest in 5N Plus, Inc. which is a supplier to the Company. 5N Plus, Inc. is based in Montreal, Canada. The investment is accounted for under the equity method of accounting and is shown as Investment on the accompanying Consolidated Balance Sheets.
At December 31, 2004 and June 30, 2004, the Company had outstanding notes receivable of approximately $0.4 million from equipment and supply agreements with 5N Plus, Inc. Payments on these notes are made quarterly with interest calculated at the Canadian Prime Rate plus 1.5% on the unpaid balance.
The Companys pro rata share of the earnings from this investment and the interest received from these agreements was $67,000 and $140,000 for the three and six month periods ended December 31, 2004 and $18,000 and $3,000 for the three and six month periods ended December 31, 2003.
18
II-VI Incorporated and Subsidiaries
Notes to Consolidated Financial Statements (Unaudited), Continued
Note N - Acquisition of Marlow Industries, Inc.
In December 2004, the Company acquired the outstanding shares of Marlow Industries, Inc. (Marlow) for approximately $29.7 million net of cash acquired of $2.9 million and including transaction costs of approximately $0.3 million, subject to certain post-closing adjustments. Marlow is a global leader in the design and manufacture of thermoelectric solutions for both cooling and power generation based on compound semiconductor materials. Marlows products are sold in a variety of markets, including defense, space, photonics, telecommunications, medical, consumer and industrial markets. As a result of the acquisition, the Company is expected to recognize synergies in material growth technology and utilization of its worldwide manufacturing and distribution networks to increase the operational and financial results of the combined companies. The financial results of Marlow are included for one month in the Companys financial results for both the three and six month periods ended December 31, 2004.
The acquisition was accounted for using the purchase method in accordance with Statement of Financial Accounting Standards No. 141 Business Combinations. Accordingly, the Company recorded the net assets at their estimated fair values, and included operating results in the consolidated financial statements since December 2004. The Company is presently in the process of obtaining a third-party valuation of the intangible assets acquired from Marlow and finalizing their deferred income tax assets and liabilities; thus the allocation of purchase price among goodwill, intangible assets not subject to amortization, intangible assets subject to amortization and deferred income tax assets and liabilities as well as determination of their related amortization periods, has not yet been finalized and are therefore subject to adjustment in future periods. The Company anticipates finalizing its accounting for the purchase of Marlow Industries, Inc. by June 30, 2005. The following table presents the allocation of the purchase price to the assets acquired and liabilities assumed at the date of acquisition ($000s).
Assets |
|||
Accounts receivable, net |
$ | 4,421 | |
Inventories |
3,969 | ||
Prepaid and other current assets |
23 | ||
Property, plant, and equipment |
8,259 | ||
Goodwill |
17,666 | ||
Other assets |
1,227 | ||
Total assets acquired |
$ | 35,565 | |
Liabilities |
|||
Accounts payable |
$ | 3,134 | |
Accrued liabilities |
1,593 | ||
Other long-term liabilities |
1,188 | ||
Total liabilities assumed |
$ | 5,915 | |
Net assets acquired |
$ | 29,650 | |
19
II-VI Incorporated and Subsidiaries
Notes to Consolidated Financial Statements (Unaudited), Continued
Note N - Acquisition of Marlow Industries, Inc., Contd.
The Consolidated Statements of Earnings includes the results of Marlow since December 2004. The following unaudited pro-forma consolidated results of operations have been prepared as if the acquisition of Marlow had occurred at July 1, 2003, the beginning of the Companys fiscal year 2004 ($000 except per share).
Three Months Ended December 31, |
Six Months Ended December 31, | |||||||||||
2004 |
2003 |
2004 |
2003 | |||||||||
Net Revenues |
$ | 47,743 | $ | 39,553 | $ | 94,968 | $ | 78,402 | ||||
Net Income |
$ | 5,576 | $ | 2,872 | $ | 11,237 | $ | 5,220 | ||||
Basic earnings per share |
$ | 0.38 | $ | 0.20 | $ | 0.77 | $ | 0.37 | ||||
Dilutive earnings per share |
$ | 0.37 | $ | 0.20 | $ | 0.75 | $ | 0.36 |
The pro-forma results are not necessarily indicative of what actually would have occurred if the transaction had taken place at the beginning of the period, are not intended to be a projection of future results and do not reflect any cost savings that might be achieved from the combined operations.
Note O - Legal Proceedings
During the quarter ended September 30, 2003, the Company was awarded a jury verdict in the amount of $0.8 million in a trade secret lawsuit which it had initiated. In addition, the Company was initially entitled to punitive damages and reimbursement of its attorneys fees and costs at the discretion of the court. On April 27, 2004, the court denied the award relating to punitive damages and reimbursement of its attorneys fees and costs. The Company and the Defendant have appealed the decision by the lower court. In December 2004, the Company filed its brief with the court of appeals. As such, the Company has not made any adjustments to its financial position or results of operations for this contingent gain.
Note P - New Accounting Pronouncements
In November 2004, the FASB issued SFAS No. 151 Inventory Costs, an amendment of Accounting Research Bulletin No. 43, Inventory Pricing. SFAS No. 151 requires all companies to recognize a current-period charge for abnormal amounts of idle facility expense, freight, handling costs and wasted materials. The statement also requires that the allocation of fixed production overhead to the costs of conversion be based on the normal capacity of the production facilities. This new standard will be effective for inventory costs incurred during fiscal years beginning after June 15, 2005. The Company is currently evaluating the effect that the accounting change will have on its financial position and results of operations.
In December 2004, the FASB issued Staff Position (FSP) No. 109-1, Application of FASB Statement No. 109, Accounting for Income Taxes, for the Tax Deduction on qualified Production Activities Provided by the American Jobs Creation Act (the Act) of 2004. The FASB also issued FSP 109-2, Accounting and Disclosure Guidance for the Foreign Earnings Repatriation Provision within the American Jobs Creation Act of 2004. The Company is currently evaluating the impact that the Act will have on its financial position and results of operations.
20
Item 2. MANAGEMENTS DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
Forward-Looking Statements
This Managements Discussion and Analysis contains forward-looking statements as defined by Section 21E of the Securities Exchange Act of 1934, as amended, including the statements regarding projected growth rates, markets, product development, financial position, capital expenditures and foreign currency exposure. Forward-looking statements are also identified by words such as expects, anticipates, intends, plans, projects or similar expressions.
Actual results could materially differ from such statements due to the following factors: materially adverse changes in economic or industry conditions generally (including capital markets) or in the markets served by II-VI Incorporated (the Company) or its subsidiaries, the development and use of new technology and the actions of competitors.
There are additional risks that could affect the Companys business, results of operations or financial condition. Investors are encouraged to review the risk factors set forth in the Companys most recent Form 10-K as filed with the Securities and Exchange Commission on September 13, 2004.
Critical Accounting Policies
The preparation of financial statements and related disclosures in conformity with accounting principles generally accepted in the United States of America and the Companys discussion and analysis of its financial condition and results of operations requires the Companys management to make judgments, assumptions, and estimates that affect the amounts reported in its consolidated financial statements and accompanying notes. Note A of the Notes to Consolidated Financial Statements in the Companys most recent Form 10-K describes the significant accounting policies and methods used in the preparation of the Companys consolidated financial statements. Management bases its estimates on historical experience and on various other assumptions that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities. Actual results may differ from these estimates.
Management believes the Companys critical accounting policies are those related to revenue recognition, allowance for doubtful accounts, warranty reserves, inventory valuation, valuation of long-lived assets including acquired intangibles and goodwill, accrual of bonus and profit sharing estimates, accrual of income tax liability estimates, workers compensation accrual for our self insurance program, and accounting for stock-based compensation. Management believes these policies to be critical because they are both important to the portrayal of the Companys financial condition and results of operations, and they require management to make judgments and estimates about matters that are inherently uncertain.
As of December 31, 2004, there have been no significant changes with regard to the critical accounting policies disclosed in Managements Discussion and Analysis of Financial Condition and Results of Operations in our Annual Report on Form 10-K for the year ended June 30, 2004.
Introduction
We generate revenues, earnings and cash flows from developing, manufacturing and marketing high technology materials and derivative products for precision use in industrial, military, medical, security and aerospace applications. We also generate revenue, earnings and cash flows from external customer and government funded research and development contracts relating to the development and manufacture of new technologies, materials and products.
Our customer base includes original equipment manufactures, laser end users, system integrators of high-power lasers, manufacturers of equipment and devices for industrial, security and monitoring, digital radiography, thermo-electric solutions, U.S. government prime contractors and various U.S. government agencies.
21
The Management Discussions and Analysis of Financial Condition and Results of Operations for the three and six month period ended December 31, 2004 include one month of operations of the Companys recently acquired Marlow subsidiary included in the Compound Semiconductor Group.
Results of Operations
Overview ($000s except per share data)
Three Months Ended December 31, |
% Increase |
Six Months Ended December 31, |
% Increase |
|||||||||||||||
2004 |
2003 |
2004 |
2003 |
|||||||||||||||
Bookings | $ | 49,380 | $ | 41,110 | 20 | % | $ | 86,912 | $ | 75,692 | 15 | % | ||||||
Revenues | 43,213 | 34,635 | 25 | % | 83,720 | 68,729 | 22 | % | ||||||||||
Net earnings | 5,793 | 3,424 | 69 | % | 11,752 | 6,538 | 80 | % | ||||||||||
Diluted earnings per share | 0.39 | 0.23 | 70 | % | 0.79 | 0.45 | 76 | % |
Net earnings for the second quarter of fiscal 2005 were $5,793,000 ($0.39 per share-diluted) on revenues of $43,213,000. This compares to net earnings of $3,424,000 ($0.23 per share-diluted) on revenues of $34,635,000 in the second quarter of fiscal 2004. For the six months ended December 31, 2004, net earnings were $11,752,000 ($0.79 per share-diluted) on revenues of $83,720,000. This compares to net earnings of $6,538,000 ($0.45 per share-diluted) on revenues of $68,729,000 for the six months ended December 31, 2003. The increase in net earnings for the current fiscal three and six month periods is primarily attributed to an increase in revenues of 25% and 22% for both the three and six month periods, respectively, compared to the same quarters last fiscal year. The increase in revenues was primarily driven by both the Infrared Optics and Near-Infrared Optics segments which has experienced increased product demands as the pace of both laser production and usage have increased. In addition to the increase in revenues, improved operating results from these two segments impacted net earnings favorably. This earnings improvement was due to operating efficiencies and cost savings realized through increased manufacturing performed at the Companys Singapore and China facilities and the lowering of the effective tax rate for the current three and six month periods based on a new tax program offered to II-VI Singapore by the Singapore government effective July 1, 2004.
Bookings for the second quarter of fiscal 2005 increased 20% to $49,380,000 compared to $41,110,000 for the same period last fiscal year. Bookings are defined as customer orders received that are expected to be converted to revenues over the next twelve months. For long-term customer orders, the Company does not include in bookings the portion of the customer order that is beyond 12 months due to the inherent uncertainty of an order that far out in the future. Compound Semiconductor Group, Infrared Optics and Near-Infrared Optics showed the strongest increases in bookings for the second quarter of fiscal 2005 compared to the same period last fiscal year. The Compound Semiconductor Groups bookings increased approximately $7.3 million, which included $4.1 million of bookings from Marlow which was acquired in December 2004. In addition to the bookings from Marlow, the Groups eV PRODUCTS division increased bookings by approximately $3.0 million due to the receipt of a yearly blanket order and product development contracts. Infrared Optics bookings increased 19% for the second quarter of fiscal 2005 compared to the same period last fiscal year due to stronger market demands from both Original Equipment Manufacturers (OEMs) and aftermarket customers in the industrial carbon dioxide (CO2) laser optics market. The Near-Infrared Optics bookings increased 29% for the second quarter of fiscal 2005 compared to the same period last fiscal year as all product lines have realized year over year growth including the Ultra Violet (UV) filter product line and custom laser crystal product lines. This increase in bookings was partially offset by a decrease in Military Infrared Optics bookings believed to be delayed to the next fiscal quarter. Bookings for contract research and development for the second quarter of fiscal 2005 of $1,757,000 increased 138% compared to $737,000 for the same period last fiscal year. The increase in contract research and development bookings is due to receiving two contract bookings totaling approximately $0.9 million in the Compound Semiconductor Group to fund the production of Cadmium Zinc Tellurium and Silicon Carbide materials. In addition, the Near-Infrared Optics segment received a contract valued at approximately $0.8 million to assist in the development of Potassium Nickel Sulfate used in the Companys UV filter product line.
22
Bookings for the six months ended December 31, 2004 increased 15% to $86,912,000 compared to $75,692,000 for the same period last fiscal year. Bookings for contract research and development for the six months ended December 31, 2004 were $3,207,000 compared to $2,049,000 for the same period last fiscal year. The increase in bookings for the six months ended December 31, 2004 compared to the same period last fiscal year is due to the same general factors mentioned above.
Bookings, revenues and segment earnings (loss) for the Companys reportable segments are discussed below. Segment earnings is a non-GAAP financial measure and differs from income from operations in that segment earnings excludes certain operational expenses included in interest expense and other income, net as reported. Management believes segment earnings to be a useful measure as it reflects the results of segment performance over which management has direct control. See also Note I to the Companys consolidated financial statements.
Infrared Optics ($000s)
Three Months Ended December 31, |
% Increase |
Six Months Ended December 31, |
% Increase |
|||||||||||||||
2004 |
2003 |
2004 |
2003 |
|||||||||||||||
Bookings | $ | 26,070 | $ | 21,851 | 19 | % | $ | 49,056 | $ | 44,175 | 11 | % | ||||||
Revenues | 23,513 | 19,891 | 18 | % | 46,578 | 39,797 | 17 | % | ||||||||||
Segment earnings | 7,705 | 5,158 | 49 | % | 15,240 | 10,609 | 44 | % |
Bookings for the second quarter of fiscal 2005 for Infrared Optics increased 19% to $26,070,000 from $21,851,000 in the second quarter of last fiscal year. Demand from OEMs who use infrared optics in their laser systems are strong across all markets serviced. Demand is expected to remain strong for the near-term as manufacturing companies worldwide continue to invest in laser equipment to increase productivity and lower costs. The markets for low power applications, such as marking and engraving, continue to grow. Bookings for the six months ended December 31, 2004 increased 11% to $49,056,000 from $44,175,000 for the same period last fiscal year. Bookings for the six month period grew at a slower pace than the second quarter due to the timing of bookings recorded by the Companys majority-owned subsidiary II-VI LOT Suisse S.a.r.l. Bookings recorded from that part of the world will occur on a more continual basis. When LOT Suisse was an independent distributor for the Company, a significant twelve-month contract was booked in the first quarter of each fiscal year, including the first quarter of last fiscal year. For the six months ended December 31, 2004, infrared optics bookings increased approximately 17% as compared to the same period last fiscal year when bookings from Switzerland of approximately $2,607,000 and $4,595,000 for the six months ended December 31, 2004 and 2003, respectively, are removed from both periods.
Revenues for the second quarter of fiscal 2005 for Infrared Optics increased 18% to $23,513,000 from $19,891,000 in the second quarter of last fiscal year. This increase was primarily attributable to increased shipment volume to both OEM and aftermarket customers. The Infrared Optics business continues to strengthen as the U.S. and Japanese economies continue to strengthen. Revenues for the six months ended December 31, 2004 increased 17% to $46,578,000 from $39,797,000 for the same period last fiscal year as the stronger order intake has translated into stronger revenues for the current period.
Segment earnings for the second quarter of fiscal 2005 increased 49% to $7,705,000 from $5,158,000 in the second quarter of last fiscal year. Segment earnings for the six months ended December 31, 2004 increased 44% to $15,240,000 from $10,609,000 for the same period last fiscal year. The improvement in segment earnings for the current fiscal three and six month periods was due to a combination of increased sales volume, an increased level of manufacturing at the Companys Asian facilities in Singapore and China and productivity improvements occurring at our various manufacturing facilities.
23
Near-Infrared Optics ($000s)
Three Months Ended December 31, |
% Increase |
Six Months Ended December 31, |
% Increase |
|||||||||||||||
2004 |
2003 |
2004 |
2003 |
|||||||||||||||
Bookings | $ | 9,015 | $ | 6,963 | 29 | % | $ | 16,070 | $ | 11,573 | 39 | % | ||||||
Revenues | 8,313 | 5,181 | 60 | % | 16,060 | 11,132 | 44 | % | ||||||||||
Segment earnings | 531 | 148 | 259 | % | 997 | 692 | 44 | % |
Bookings for the second quarter of fiscal 2005 for Near-Infrared Optics increased 29% to $9,015,000 from $6,963,000 in the second quarter of last fiscal year. Bookings for the six months ended December 31, 2004 were $16,070,000 compared to $11,573,000 for the same period last fiscal year. The increase in bookings for the current fiscal three and six month periods is primarily driven by bookings for the UV filter product line used to assist aircraft in the early detection of missile threats. In addition to bookings for the UV filters product line, stronger bookings were received from various military programs such as counter measure weapon systems, detection systems and target designators.
Revenues for the second quarter of fiscal 2005 for Near-Infrared Optics increased 60% to $8,313,000 compared to $5,181,000 in the second quarter of last fiscal year. Revenues for the six months ended December 31, 2004 increased 44% to $16,060,000 from $11,132,000 for the same period last fiscal year. This increase in revenues for both the current fiscal three and six month periods was attributed to revenues from the UV filter product line. During the current fiscal year, increased customer delivery requirements of the UV filter product line drove the revenue increase. In addition, increased shipments of standard optics and crystal products used in the military market contributed to the revenue increase.
Segment earnings for the second quarter of fiscal 2005 increased 259% to $531,000 from $148,000 in the second quarter of last fiscal year. Segment earnings for the six months ended increased 44% to $997,000 from $692,000 for the same period last fiscal year. The primary contributor to the increase in segment earnings is due to the increase in revenues for both the three and six month periods ended December 31, 2004.
Military Infrared Optics ($000s)
Three Months Ended December 31, |
% Increase (Decrease) |
Six Months Ended December 31, |
% Increase (Decrease) |
|||||||||||||||
2004 |
2003 |
2004 |
2003 |
|||||||||||||||
Bookings | $ | 5,275 | $ | 10,559 | (50 | )% | $ | 10,917 | $ | 16,664 | (34 | )% | ||||||
Revenues | 6,684 | 6,517 | 3 | % | 13,095 | 12,199 | 7 | % | ||||||||||
Segment earnings | 358 | 245 | 46 | % | 639 | 239 | 167 | % |
Bookings for the second quarter of fiscal 2005 for Military Infrared Optics decreased 50% to $5,275,000 as compared to $10,559,000 in the second quarter of last fiscal year. Bookings for the six months ended December 31, 2004 decreased 34% to $10,917,000 as compared to $16,664,000 for the same period last fiscal year. The overall decrease in bookings for both the current fiscal three and six month periods was due in part to a slowdown in military procurement relating to the war efforts. In addition, planned reduction in the Javelin Missile Program and procurement delays for other military programs have all contributed to this decrease. The decrease in bookings was partially offset during the three months ended December 31, 2004 as the Company booked the first significant order for the Joint Strike Fighter of approximately $1.5 million.
Revenues for the second quarter of fiscal 2005 for Military Infrared Optics increased 3% to $6,684,000 compared to $6,517,000 in the second quarter last fiscal year. Revenues for the six months ended December 31, 2004 increased 7% to $13,095,000 compared to $12,199,000 for the same period last fiscal year. Contributing to the increase in revenues was the continued progress of the segments sapphire window assembly product line for the three and six months ended December 31, 2004. In addition to the sapphire window assembly, the demand for core military products has also contributed to the revenue increase.
24
Segment earnings for the second quarter of fiscal 2005 increased 46% to $358,000 compared to segment earnings of $245,000 for the same period last fiscal year. Segment earnings for the six months ended December 31, 2004 increased 167% to $639,000 compared to $239,000 for the same period last fiscal year. The improvement in segment earnings for the three and six month periods of the current fiscal year was primarily due to an increase in revenue for both periods. In addition, during the prior fiscal year the Company incurred losses from activities performed on a fixed price percentage of completion contract which was terminated during the fiscal year ended June 30, 2004.
Compound Semiconductor Group ($000s)
Three Months Ended December 31, |
% Increase |
Six Months Ended December 31, |
% (Decrease) |
|||||||||||||||||||
2004 |
2003 |
2004 |
2003 |
|||||||||||||||||||
Bookings | $ | 9,020 | $ | 1,737 | 419 | % | $ | 10,869 | $ | 3,288 | 231 | % | ||||||||||
Revenues | 4,703 | 3,046 | 54 | % | 7,987 | 5,601 | 43 | % | ||||||||||||||
Segment (loss) | (774 | ) | (432 | ) | (79 | %) | (1,320 | ) | (1,697 | ) | (22 | )% |
The Companys Compound Semiconductor Group includes the combined operations of the Companys eV PRODUCTS division, the Companys WBG group, the Companys AMDC group and one-month financial results of Marlow for both the three and six month periods ended December 31, 2004.
Bookings for the second quarter of fiscal 2005 for the Compound Semiconductor Group were $9,020,000 as compared to $1,737,000 in the second quarter of last fiscal year. Bookings for the six months ended December 31, 2004 were $10,869,000 compared to $3,288,000 for the same period last fiscal year. Included in the current fiscal three and six months bookings were approximately $4.1 million of bookings from Marlow Other increases in bookings for the Group included bookings in the eV PRODUCTS division for a yearly blanket order of approximately $2.2 million for their bone mineral densitometry detectors and product development and contract bookings totaling approximately $1.1 million. During the second quarter ended December 31, 2004 the WBG group recorded its first booking from a multi-year military cost-sharing contract for the production of high quality 4-inch silicon carbide substrates for use in advanced wide bandgap semiconductor RF devices. Under the Companys bookings policy the group recorded approximately $0.5 million under this contract during the quarter.
Revenues for the second quarter of fiscal 2005 for the Compound Semiconductor Group were $4,703,000 compared to $3,046,000 in the second quarter of the last fiscal year. Revenues for the six months ended December 31, 2004 were $7,987,000 compared to $5,601,000 for the same period last fiscal year. Included in the current fiscal three and six month periods were revenues of approximately $2.3 million from Marlow. Excluding the revenues of Marlow, revenues for the Compound Semiconductor Group for the three months ended December 31, 2004 decreased approximately $0.6 million or 21% from the same period last fiscal year. The decrease in revenues was attributed primarily to a lowering of demand for the Groups bone mineral densitometry product line from its major medical imaging customer. For the six month period ended December 31, 2004 revenues excluding Marlow, were $5.7 million compared to $5.6 million for the same period last fiscal year.
The segment loss for the second quarter of fiscal 2005 of $774,000 increased from the segment loss of $432,000 in the second quarter of the prior fiscal year. The increase in segment loss for the three months ended December 31, 2004 compared to the same period last fiscal year was primarily due to lower revenues from the Groups eV PRODUCTS divisions bone mineral densitometry radiation sensor products. The segment loss of $1,320,000 for the six months ended December 31, 2004 decreased from the segment loss of $1,697,000 for the same period last fiscal year. The improvement in the segment loss for the six months ended December 31, 2004 compared to the same period last fiscal year was primarily due to improved operating results of the WBG group due to an increase in contract revenue as well as one month of segment earnings from Marlow.
25
Overall
Manufacturing gross margin, which is calculated as net sales less cost of goods sold, for the second quarter of fiscal 2005 was $18,275,000 or 44% of net sales compared to $13,982,000 or 42% of net sales for the same period last fiscal year. Manufacturing gross margin for the six months ended December 31, 2004 was $35,685,000 or 45% of revenue compared to $27,969,000 or 43% of revenues for the same period last fiscal year. The increased sales volume for the current periods as compared to the same periods last fiscal year and the increase in the amount of manufacturing performed at the Companys Singapore and China facilities all impacted gross margins favorably for both the three and six month periods. The Company manufacturing gross margin for three and six months ended December 31, 2004 has started to be impacted unfavorably due to the increases in the Companys raw materials cost. Specifically, the Infrared Optics segment has experienced a sharp increase in the price of selenium, which has seen the cost per pound increase from approximately $4.00 per pound to approximately $38.00 per pound over the last 18 months.
Contract research and development gross margin, which is calculated as contract research and development revenues less contract research and development expenses, for the second quarter of fiscal 2005 was $842,000 or 48% of research and development revenues compared to a gross margin of $286,000 or 17% of research and development revenues for the same period last fiscal year. Contract research and development gross margin for the six months ended December 31, 2004 was $1,217,000 or 27% of research and development revenue compared to a gross margin of $336,000 or 9% of research and development revenue for the same period last fiscal year. The increase in the contract research and development gross margin for the three and six months ended December 31, 2004 was due to losses recognized in the prior fiscal year from activities performed on a fixed price percentage of completion contract in the Military Optics segment. During the six month period ended December 31, 2004, the Company recognized approximately $144,000 of gross margin on this contract compared to a loss of $196,000 for the same period last fiscal year. In addition to the improvement in gross margin in the Military Optics segment, gross margin improvements were realized on contracts in the Compound Semiconductor Group. The contract research and development revenues and costs are a result of development efforts in the Near-Infrared Optics and the Military Infrared Optics segments as well as activities in the eV PRODUCTS division and the WBG group for the current quarter. Contract research and development gross margin is a result of cost plus fixed fee, cost reimbursement and percentage of completion contract activities.
Company-funded internal research and development expenses for the second quarter of fiscal 2005 were $1,584,000 or 4% of revenue were consistent with the same period last fiscal year of $1,367,000 or 4% of revenues. Company funded internal research and development expenses for the six months ended December 31, 2004 were $2,632,000 or 3% of revenues compared to $2,454,000 or 4% of revenues. The internal research and development expenses for the last two quarters of fiscal year 2005 is expected to be higher than the just recently completed periods due to a full quarter internal research and development at Marlow.
Selling, general and administrative expenses for the second quarter of fiscal 2005 were $9,713,000 or 22% of revenues compared to $7,782,000 or 22% of revenues for the same period last fiscal year. Selling, general and administrative expenses for the six months ended December 31, 2004 were $18,714,000 or 22% of revenues compared to $16,008,000 or 23% of revenues for the same period last year. The dollar increase for the three and six month periods primarily reflects increased salary expenses for the Companys worldwide profit driven bonus program.
Interest expense for the second quarter of fiscal 2005 was $88,000 compared to $117,000 for the same period last fiscal year. For the six months ended December 31, 2004, interest expense was $151,000 compared to $251,000 for the same period last fiscal year. During the month of December 2004, in connection with the acquisition of Marlow the Company replaced its existing $45.0 million credit facility scheduled to expire August 2005 with a new $60.0 million credit facility (see Note F). The increase in interest expense due to borrowings related to the Marlow acquisition was more than offset by lower average debt levels during the current quarter than during the prior fiscal quarter as well as the the capitalization of approximately $0.1 million of interest for the Companys coating and administration facility expansion in progress at the Saxonburg, Pennsylvania facility.
26
Other income for the second quarter of fiscal 2005 was $203,000 compared to other income of $149,000 for the same period last fiscal year. Other income for the six months ended December 31, 2004 was $694,000 compared to $240,000 of other income for the same period last fiscal year. These income items for both the three and six month periods included foreign currency gains, earnings from our one-third interest in 5NPlus, Inc. and other income items. Other income was partially offset by the minority interests in our majority-owned subsidiaries in Germany and Switzerland, the write-off of debt issuance costs associated with the credit facility the Company replaced before its maturity date, and other expense items.
The Companys year-to-date effective income tax rate is 27% compared to an effective income tax rate of 33% for the same period in fiscal 2004. The decrease in the effective tax rate is the result of an expected shift in the mix of taxable earnings to lower tax rate jurisdictions as well as a lower tax rate on the Singapore operations based on a new tax program offered to II-VI Singapore by the Singapore government effective July 1, 2004. The American Jobs Creation Act of 2004, signed into law in October 2004, provides for a variety of changes in the tax law including incentives to repatriate undistributed earnings of foreign subsidiaries, phased elimination of the Foreign Sales Corporation/Extraterritorial Income benefit and a domestic manufacturing benefit. We are currently evaluating the potential impact of this legislation, including assessing the details of the Act, analyzing the funds available for repatriation and the economic cost of doing so, assessing the qualified uses of repatriated funds and assessing the domestic manufacturing benefit. However, given the preliminary stage of our evaluation, at this time it is not possible to determine what impact this legislation may have on the Companys effective tax rate.
Liquidity and Capital Resources
Historically, our primary source of cash has been provided through operations. Other sources of cash include proceeds received from the exercise of stock options, as well as through long-term borrowings. Our historical uses of cash have been for capital expenditures, purchases of businesses, and payment of principal and interest on outstanding debt obligations. Supplemental information pertaining to our sources and uses of cash is presented as follows:
Sources (uses) of Cash:
Six Months Ended December 31, |
||||||||
2004 |
2003 |
|||||||
Net cash provided by operating activities |
$ | 3,267 | $ | 10,513 | ||||
Proceeds from exercise of stock options |
1,029 | 586 | ||||||
Additions to property, plant and equipment |
(7,975 | ) | (5,719 | ) | ||||
Purchases of businesses, net of cash acquired |
(29,650 | ) | (1,954 | ) | ||||
Net borrowings net of cash acquired on long-term borrowings |
28,000 | (3,397 | ) |
In the first six months of fiscal 2005, cash provided by operations was approximately $3.3 million. The increase in cash was driven by the Companys net earnings of approximately $11.8 million along with depreciation and amortization expense of approximately $5.5 million and a decrease in accounts receivable of approximately $2.4 million. The increase in cash was offset by working capital requirement (inventories, accounts payable and other operating net assets) of approximately $15.8 million.
Net cash used in investing during the first six months of fiscal 2005 of approximately $37.6 million was primarily from the Companys acquisition of Marlow of approximately $29.7 million and property, plant and equipment expenditures of $8.0 million. Net cash provided by financing activities of $29.0 million included borrowings on short-term and long-term debt totaling $45.4 million, payments made on borrowings of $17.4 million and $1.0 million of proceeds from the exercise of stock options.
On December 10, 2004, the Company replaced its $45.0 million secured credit facility with a $60.0 million secured credit agreement in connection with the Companys acquisition of Marlow. This facility has a five-year term and contains a term option in the original amount of $30.0 million and a $30.0 million line of credit option.
27
The facility is collateralized by a pledge of 65% of the stock of the Companys foreign subsidiaries. Additionally, the facility is subject to certain restrictive covenants, including those relating to minimum net worth, leverage and consolidated debt service coverage. The facility has an interest rate range of LIBOR plus 0.75% to LIBOR plus 1.50%. Principal payments of $1.9 million under the term loan are payable in quarterly installments beginning January 1, 2006. The weighted average interest rate of borrowings under the new credit agreement was 3.60% at December 31, 2004. The Company had available $19.1 million under its line of credit as of December 31, 2004.
The Company is expanding its coating facility and administrative offices at its Saxonburg, Pennsylvania facility. Estimated total costs of the expansion project are expected to approximate $9.6 million. As of December 31, 2004 approximately $3.8 million has been incurred; the remaining amounts will be funded from cash generated from operations.
Our cash position, borrowing capacity and debt obligations are as follows:
($000)
December 31, 2004 |
June 30, 2004 | |||||
Cash and cash equivalents |
$ | 16,270 | $ | 21,683 | ||
Available borrowing capacity |
19,100 | 16,600 | ||||
Total debt obligations |
43,711 | 15,536 |
The Company believes cash flow from operations, existing cash reserves and available borrowing capacity will be sufficient to fund its working capital needs, capital expenditures, scheduled debt payments and growth for the remainder of fiscal 2005.
Contractual Obligations
The following table presents information about our contractual obligations and commitments as of December 31 2004.
TABULAR DISCLOSURE OF CONTRACTUAL OBLIGATIONS
Payments Due By Period | |||||||||||||||
Contractual Obligations | Total |
Less Than 1 Year |
1-3 Years |
3-5 Years |
More Than 5 Years | ||||||||||
($000s) |
|||||||||||||||
Long-Term Debt Obligations |
$ | 43,711 | $ | 51 | $ | 25,536 | $ | 18,011 | $ | 113 | |||||
Capital Lease Obligations |
| | | | | ||||||||||
Operating Lease Obligations |
2,158 | 1,147 | 940 | 71 | | ||||||||||
Purchase Obligations |
14,934 | 7,216 | 7,718 | | | ||||||||||
Other Long-Term Liabilities Reflected on the Registrants Balance Sheet |
| | | | | ||||||||||
Total |
$ | 60,803 | $ | 8,414 | $ | 34,194 | $ | 18,082 | $ | 113 |
28
Item 3. QUANTITATIVE AND QUALITATIVE DISCLOSURE ABOUT MARKET RISK
Foreign Exchange Risks
The Company is exposed to market risks arising from adverse changes in foreign currency exchange rates and interest rates. In the normal course of business, the Company uses a variety of techniques and derivative financial instruments as part of its overall risk management strategy primarily focused on its exposure to the Japanese Yen. No significant changes have occurred in the techniques and instruments used other than those described below.
The Company also has transactions denominated in Euros and Pounds Sterling. Changes in the foreign currency exchange rates of these currencies did not have a material impact on the results of operations for the quarter ended December 31, 2004.
In the normal course of business, the Company enters into foreign currency forward exchange contracts with its banks. The purpose of these contracts is to hedge ordinary business risks regarding foreign currencies on product sales. Foreign currency exchange contracts are used to limit transactional exposure to changes in currency rates. The Company enters into foreign currency forward contracts that permit it to sell specified amounts of foreign currencies expected to be received from its export sales for pre-established U.S. dollar amounts at specified dates. The forward contracts are denominated in the same foreign currencies in which export sales are denominated. These contracts provide the Company with an economic hedge in which settlement will occur in future periods and which otherwise would expose the Company to foreign currency risk. The Company monitors its positions and the credit ratings of the parties to these contracts. While the Company may be exposed to potential losses due to risk in the event of non-performance by the counterparties to these financial instruments, it does not anticipate such losses. The Company entered into a low interest rate, 300 million Yen loan with PNC Bank in September 2002 in an effort to minimize the foreign currency exposure in Japan. A change in the interest rate of 1% for this Yen loan would have changed the interest expense by approximately $7,000 and $14,000 for the three months and six months ended December 31, 2004 and a 10% change in the Yen to dollar exchange rate would have changed revenues in the range from a decrease of $429,000 to an increase of $542,000 for the three months ended December 31, 2004 and in the range from a decrease of $834,000 to an increase of $1,029,000 for the six months ended December 31, 2004.
For II-VI Singapore Pte., Ltd. and its subsidiaries, the functional currency is the U.S. dollar. Gains and losses on the remeasurement of the local currency financial statements are included in net earnings. Foreign currency remeasurement gains (losses) were $(35,000) and $156,000 for the three and six month periods ended December 31, 2004, respectively, and $324,000 and $424,000 for the three and six month periods ended December 31, 2003, respectively.
For all other foreign subsidiaries, the functional currency is the local currency. Assets and liabilities of those operations are translated into U.S. dollars using period-end exchange rates; while income and expenses are translated using the average exchange rates for the reporting period. Translation adjustments are recorded as accumulated other comprehensive income within shareholders equity.
Interest Rate Risks
On March 9, 2004, the Company entered into a one-year interest rate cap, replacing an existing interest rate cap that matured on March 6, 2004, with a notional amount of $5.6 million as required under the terms of its previous credit agreement in order to limit interest rate exposure on one-half of the then outstanding balance of the term loan. During the quarter ended December 31, 2004, the Company increased its borrowings in connection with the acquisition of Marlow by $28.2 million. As of December 31, 2004, the total borrowings of $43.7 million include $30.0 million under the term loan option, $10.4 million under the line of credit option, a $2.9 million Japanese Yen loan and a $0.4 million Pennsylvania Industrial Development Authority term note. As such, the Company is exposed to changes in interest rates. A change in the interest rate of 1% would have changed the interest expense by approximately $76,000 and $148,000 for the three and six months ended December 31, 2004, respectively.
29
Item 4. CONTROLS AND PROCEDURES
The Companys management evaluated, with the participation of Carl J. Johnson, the Companys Chairman and Chief Executive Officer, and Craig A. Creaturo, the Companys Chief Financial Officer and Treasurer, the effectiveness of the Companys disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) as of the end of the period covered by this quarterly report on Form 10-Q. The Companys disclosure controls were designed to provide reasonable assurance that information required to be disclosed in reports that we file or submit under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the Securities and Exchange Commission. It should be noted that the design of any system of controls is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions, regardless of how remote. However, the controls have been designed to provide reasonable assurance of achieving the controls stated goals. Based on that evaluation, Messrs. Johnson and Creaturo concluded that the Companys disclosure controls and procedures are effective at the reasonable assurance level. There were no changes in the Companys internal control over financial reporting that occurred during the Companys most recent fiscal quarter that have materially affected or are reasonably likely to materially affect the Companys internal control over financial reporting.
Item 4a. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS
On November 5, 2004, the Company held its annual meeting of shareholders. The three matters voted upon at the annual meeting were (1) the election of two directors for a term to expire in 2007, (2) the ratification of the Board of Directors selection of Deloitte & Touche LLP as the Companys independent registered public accounting firm for the fiscal year ending June 30, 2005 and (3) an amendment to the Companys Articles of Incorporation to increase the number of shares of common stock that are authorized to issue from 30,000,000 to 100,000,000 shares.
Each of the nominees for director were reelected at the annual meeting. The following is a separate tabulation with respect to each director:
Votes For |
Votes Withheld |
Total Votes | ||||
Peter W. Sognefest |
13,399,192 | 852,005 | 14,251,197 | |||
Francis J. Kramer |
13,633,237 | 617,960 | 14,251,197 |
The total number of votes cast on the ratification of the appointment of Deloitte & Touche LLP as the Companys independent registered public accounting firm for the fiscal year ending June 30, 2005 was 14,252,807 with 13,711,153 votes for, 524,971 votes against and 16,683 votes abstaining.
The total number of votes cast regarding the Companys amendment to its Articles of Incorporation to increase the number of shares of common stock that are authorized to issue from 30,000,000 to 100,000,000 shares was 14,252,807 with 9,116,866 votes for 5,118,507 votes against and 17,434 votes abstaining.
There were no broker non-votes on these matters.
30
Exhibit Number |
Description of Exhibit |
Reference | ||
2.1 | Agreement and Plan of Merger by and among II-VI Incorporated and II-VI Acquisition Co. and Marlow Industries, Inc. and its Shareholders dated as of December 10, 2004. | Incorporated by reference is Exhibit 2.1 to II-VIs Form 8-K | ||
10.1 | $30,000,000 Revolving Credit Facility $30,000,000 Term Loan Credit Agreement by and among II-VI Incorporated, its subsidiary guarantors, various lenders and PNC Bank, National Association dated December 10, 2004. | Incorporated by reference is Exhibit 10.1 to II-VIs Form 8-K | ||
21.01 | List of Subsidiaries of II-VI Incorporated | Filed herewith. | ||
31.01 | Certification of the Chief Executive Officer pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934, as amended, and Section 302 of the Sarbanes-Oxley Act of 2002 | Filed herewith. | ||
31.02 | Certification of the Chief Financial Officer pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934, as amended, and Section 302 of the Sarbanes-Oxley Act of 2002 | Filed herewith. | ||
32.01 | Certification of the Chief Executive Officer pursuant to Rule 13a-14(b) of the Securities Exchange Act of 1934, as amended, and 18 U.S.C. § 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 | Filed herewith. | ||
32.02 | Certification of the Chief Financial Officer pursuant to Rule 13a-14(b) of the Securities Exchange Act of 1934, as amended, and 18 U.S.C. § 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 | Filed herewith. |
31
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
II-VI INCORPORATED | ||||
(Registrant) | ||||
Date: February 9, 2005 | By: | /s/ Carl J. Johnson | ||
Carl J. Johnson | ||||
Chairman and Chief Executive Officer | ||||
Date: February 9, 2005 | By: | /s/ Craig A. Creaturo | ||
Craig A. Creaturo | ||||
Chief Financial Officer and Treasurer |
32
EXHIBIT INDEX
Exhibit Number |
Description of Exhibit |
Reference | ||
2.1 | Agreement and Plan of Merger by and among II-VI Incorporated and II-VI Acquisition Co. and Marlow Industries, Inc. and its Shareholders dated as of December 10, 2004. | Incorporated by reference is Exhibit 2.1 to II-VIs Form 8-K | ||
10.1 | $30,000,000 Revolving Credit Facility $30,000,000 Term Loan Credit Agreement by and among II-VI Incorporated, its subsidiary guarantors, various lenders and PNC Bank, National Association dated December 10, 2004. | Incorporated by reference is Exhibit 10.1 to II-VIs Form 8-K | ||
21.01 | List of Subsidiaries of II-VI Incorporated | Filed herewith. | ||
31.01 | Certification of the Chief Executive Officer pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934, as amended, and Section 302 of the Sarbanes-Oxley Act of 2002 | Filed herewith. | ||
31.02 | Certification of the Chief Financial Officer pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934, as amended, and Section 302 of the Sarbanes-Oxley Act of 2002 | Filed herewith. | ||
32.01 | Certification of the Chief Executive Officer pursuant to Rule 13a-14(b) of the Securities Exchange Act of 1934, as amended, and 18 U.S.C. § 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 | Filed herewith. | ||
32.02 | Certification of the Chief Financial Officer pursuant to Rule 13a-14(b) of the Securities Exchange Act of 1934, as amended, and 18 U.S.C. § 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 | Filed herewith. |
33